Taiwan · Delayed Price · Currency is TWD Steminent Biotherapeutics Statistics
Total Valuation
TPEX:7729 has a market cap or net worth of TWD 5.56 billion. The enterprise value is 5.48 billion.
| Market Cap | 5.56B |
| Enterprise Value | 5.48B |
Important Dates
The next estimated earnings date is Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7729 has 66.63 million shares outstanding. The number of shares has increased by 2.35% in one year.
| Current Share Class | 66.63M |
| Shares Outstanding | 66.63M |
| Shares Change (YoY) | +2.35% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 3.46% |
| Float | 52.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 11.88 |
| P/TBV Ratio | 11.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -34.98 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.06
| Current Ratio | 11.06 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -340.61 |
Financial Efficiency
Return on equity (ROE) is -38.09% and return on invested capital (ROIC) is -22.01%.
| Return on Equity (ROE) | -38.09% |
| Return on Assets (ROA) | -19.45% |
| Return on Invested Capital (ROIC) | -22.01% |
| Return on Capital Employed (ROCE) | -29.34% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 47 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:7729 has paid 72,500 in taxes.
| Income Tax | 72,500 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +229.29% in the last 52 weeks. The beta is 0.41, so TPEX:7729's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +229.29% |
| 50-Day Moving Average | 79.41 |
| 200-Day Moving Average | 47.37 |
| Relative Strength Index (RSI) | 48.56 |
| Average Volume (20 Days) | 559,393 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.41M |
| Operating Income | -156.17M |
| Pretax Income | -156.68M |
| Net Income | -156.75M |
| EBITDA | -141.00M |
| EBIT | -156.17M |
| Earnings Per Share (EPS) | -2.79 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 468.45M |
| Book Value Per Share | 8.33 |
| Working Capital | 347.37M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 15.17M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7729 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.35% |
| Shareholder Yield | -2.35% |
| Earnings Yield | -2.82% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |